NIACINAMIDE 4% / TAZAROTENE 0.1%
NIACINAMIDE 4% / TAZAROTENE 0.1%
Approved
Approval ID
8738c9c8-17b1-b7b7-e053-2a91aa0acdfb
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 23, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
NIACINAMIDE 4% / TAZAROTENE 0.1%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2161
Product Classification
G
Generic Name
NIACINAMIDE 4% / TAZAROTENE 0.1%
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 23, 2019
FDA Product Classification
INGREDIENTS (2)
TAZAROTENEActive
Quantity: 0.1 g in 100 g
Code: 81BDR9Y8PS
Classification: ACTIB
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB